The Effect of a Combination of Orange- and Pomegranate Actives on Physical Fitness in Elderly People
NCT ID: NCT03781999
Last Updated: 2019-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2018-06-25
2019-01-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this crossover study, participants will daily receive either a placebo or Actiful®, a supplement containing 500 mg orange extract and 200 mg pomegranate actives, for 4 weeks followed by a wash-out period of 4 to 8 weeks. Subsequently, the second intervention period of 4 weeks (active product or placebo) will take place. The product and placebo will be supplied in capsules that participants can ingest with a glas of water (daily, prior to breakfast).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Sweet Orange and Pomegranate Extract Supplementation on Exercise Capacity in Middle-aged Adults
NCT05133778
The Effect of an Orange Peel Extract on Exercise Performance
NCT02787733
Astaxanthin Supplementation in Cyclists
NCT01241877
The Effect of a Citrus Extract on Exercise Performance in Moderately Trained Athletes
NCT03044444
Effects of Astaxanthin Supplementation
NCT06511960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Actiful
a supplement containing 500 mg orange extract and 200 mg pomegranate actives
Actiful
supplement containing 500 mg orange extract and 200 mg pomegranate actives
Placebo
Maltodextrin
Placebo
Maltodextrin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Actiful
supplement containing 500 mg orange extract and 200 mg pomegranate actives
Placebo
Maltodextrin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non smoking
* BMI 18 -28 kg/m²
Exclusion Criteria
* BMI lower than 18 or higher than 28
* Recent muscle injury in less than one month before the start of the study
* Inability to perform the fitness tests
* Medical conditions that might influence outcome measure or participant safety during testing, including but not limited to: severe cardiovascular disease, cancer, Parkinson's disease. To be decided by PI.
* High blood pressure (systolic ≥ 140 mmHg, diastolic ≥ 90 mmHg)
* Use of medication that may interfere with the study results, use of beta-blockers
* Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study
* Abuse of products; alcohol (\> 20 alcoholic units per week) and drugs
60 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioActor
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Freddy Troost, Dr
Role: PRINCIPAL_INVESTIGATOR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BioActor
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bednarska K, Fecka I, Scheijen JLJM, Ahles S, Vangrieken P, Schalkwijk CG. A Citrus and Pomegranate Complex Reduces Methylglyoxal in Healthy Elderly Subjects: Secondary Analysis of a Double-Blind Randomized Cross-Over Clinical Trial. Int J Mol Sci. 2023 Aug 24;24(17):13168. doi: 10.3390/ijms241713168.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Actiful_001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.